Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spirit Scientific CoROCO:7790 +0.77%21 PB Ratio is 2.62 as of Jul. 16, 2026, which is 25% below its 10-year median of 3.48. GuruFocus rates ROCO:7790 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 1,227 Biotechnology companies, Spirit Scientific Co ranks better than 54.28% on this metric.
The historical rank and industry rank for Spirit Scientific Co's PB Ratio or its related term are showing as below:
ROCO:7790'
s PB Ratio Range Over the Past 10 Years
Min: 2.22 Med: 3.48 Max: 3.85
Current: 2.62
During the past 5 years, Spirit Scientific Co's highest PB Ratio was 3.85. The lowest was 2.22. And the median was 3.48.
ROCO:7790's PB Ratio is ranked better than 54.28% of 1227
companies
in the Biotechnology industry
Industry Median: 2.93
vs ROCO:7790: 2.62
During the past 12 months, Spirit Scientific Co's average Book Value Per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 43.30% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Spirit Scientific Co was 51.80% per year. The lowest was 43.30% per year. And the median was 47.55% per year.
Back to Basics: PB Ratio
Spirit Scientific Co (ROCO:7790) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Spirit Scientific Co PB Ratio Related Terms
Spirit Scientific Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Spirit Scientific Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7790 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, Spirit Scientific Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spirit Scientific Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Spirit Scientific Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Spirit Scientific Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Spirit Scientific Co (ROCO:7790) has a PB Ratio of 2.62 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Spirit Scientific Co and its competitors. This is 25% below median its historical median of 3.48. Over the past decade, Spirit Scientific Co's PB Ratio has ranged from 2.22 to 3.85. According to the industry distribution chart, Spirit Scientific Co ranks #561 out of 1227 companies in the Biotechnology industry, placing it in the top 45.7%.
Is Spirit Scientific Co's PB Ratio too high?
Spirit Scientific Co's current PB Ratio of 2.62 is 25% below median its 10-year median of 3.48. Over the past 10 years, this metric has ranged from a low of 2.22 to a high of 3.85. The Biotechnology industry median PB Ratio is 2.93. Spirit Scientific Co's value of 2.62 is 10.6% below this industry median. Based on the distribution chart, Spirit Scientific Co ranks #561 out of 1227 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Spirit Scientific Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Spirit Scientific Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Spirit Scientific Co ranks #561 out of 1227 companies for PB Ratio. This puts Spirit Scientific Co in the upper half of its industry. The industry median PB Ratio is 2.93. Spirit Scientific Co's value of 2.62 is 10.6% below this benchmark. Historically, Spirit Scientific Co's own PB Ratio has ranged from 2.22 to 3.85 over the past decade. While the company's 10-year median is 3.48 vs. the industry median of 2.93, Spirit Scientific Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.93, based on 1,227 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spirit Scientific Co's current PB Ratio of 2.62 is 10.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Spirit Scientific Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spirit Scientific Co's current PB Ratio is 2.62, which is 25% below median its own 10-year median of 3.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spirit Scientific Co stock overvalued right now?
Spirit Scientific Co (ROCO:7790) has a current PB Ratio of 2.62. The current PB Ratio is 2.62, which is 25% below median its 10-year median of 3.48 and 10.6% below the Biotechnology industry median of 2.93. Spirit Scientific Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Spirit Scientific Co (ROCO:7790), the current PB Ratio is 2.62 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spirit Scientific Co Ltd is engaged in precision regenerative medicine, specializing in platelet cryocrystallization technology and Bio Material Lyophilized Technology (BMLT). The company provides solutions for extracting high-concentration platelet growth factors, enabling safe, flexible, and long-term storage therapies. Spirit Biotech delivers cutting-edge autologous healing reagent preparation services, along with OEM and ODM models. With a focus on unmet medical needs, the company transforms patented technologies into scalable solutions, advancing the future of regenerative healthcare.
21GF Score
Get the complete analysis for ROCO:7790
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7790 has been successfully added to your 
